Arvinas (ARVN) Non Operating Income (2017 - 2026)

Arvinas' (ARVN) quarterly Non Operating Income came in at $6.3 million in Q1 2026, down 46.15% year-on-year from $11.7 million in Q1 2025, and down 14.86% quarter-over-quarter from $7.4 million in Q4 2025.

Arvinas (ARVN) Non Operating Income (2017 - 2026) Analysis & Trends

Arvinas' Non Operating Income history runs 10 years deep, the most recent figure standing at $6.3 million for Q1 2026.

  • On a quarterly basis, Non Operating Income fell 46.15% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $32.7 million, a 34.07% decrease from a year earlier, with the FY2025 full-year figure at $38.0 million, down 26.78% from the prior year.
  • Non Operating Income eased to $6.3 million in Q1 2026 per ARVN's latest filing, from $7.4 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $14.0 million in Q1 2024 and bottomed at $1.1 million in Q1 2022.
  • The 5-year median for Non Operating Income is $9.0 million (2023), against an average of $8.6 million.
  • Across the five-year window, Non Operating Income surged 540.0% in 2022 and tumbled 46.15% in 2026, its largest moves.
  • Year by year, Non Operating Income stood at $6.3 million in 2022, then jumped by 92.06% to $12.1 million in 2023, then climbed by 4.96% to $12.7 million in 2024, then plunged by 41.73% to $7.4 million in 2025, then decreased by 14.86% to $6.3 million in 2026.
  • Per Business Quant, the three latest ARVN Non Operating Income figures stand at $6.3 million (Q1 2026), $7.4 million (Q4 2025), and $9.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -9.22 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 444,000.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 5.75 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -8.59 Mn
10 Arvinas 512.64 Mn -102.26 Mn - 6.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.30 Mn
Dec 31, 2025 7.40 Mn
Sep 30, 2025 9.00 Mn
Jun 30, 2025 10.00 Mn
Mar 31, 2025 11.70 Mn
Dec 31, 2024 12.70 Mn
Sep 30, 2024 11.70 Mn
Jun 30, 2024 13.50 Mn
Mar 31, 2024 14.00 Mn
Dec 31, 2023 12.10 Mn
Sep 30, 2023 10.00 Mn
Jun 30, 2023 9.00 Mn
Mar 31, 2023 6.50 Mn
Dec 31, 2022 6.30 Mn
Sep 30, 2022 3.20 Mn
Jun 30, 2022 1.70 Mn
Mar 31, 2022 1.10 Mn
Dec 31, 2021 1.40 Mn
Sep 30, 2021 500,000.00
Jun 30, 2021 1.60 Mn